First Community Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36K Hold
285
0.02% 211
2026
Q1
$39.7K Hold
285
0.03% 197
2025
Q4
$35K Hold
285
0.03% 204
2025
Q3
$31.6K Hold
285
0.02% 210
2025
Q2
$31.6K Hold
285
0.03% 209
2025
Q1
$31.9K Hold
285
0.03% 201
2024
Q4
$26.3K Hold
285
0.02% 216
2024
Q3
$23.9K Hold
285
0.02% 218
2024
Q2
$19.6K Hold
285
0.02% 223
2024
Q1
$20.9K Hold
285
0.02% 199
2023
Q4
$23.1K Hold
285
0.03% 190
2023
Q3
$21.4K Sell
285
-85
-23% -$6.54K 0.02% 198
2023
Q2
$28.5K Hold
370
0.03% 186
2023
Q1
$30.7K Sell
370
-100
-21% -$8.28K 0.04% 178
2022
Q4
$40K Hold
470
0.05% 170
2022
Q3
$29K Sell
470
-20
-4% -$1.26K 0.04% 166
2022
Q2
$30K Hold
490
0.04% 191
2022
Q1
$29K Buy
490
+20
+4% +$1.28K 0.03% 218
2021
Q4
$34.1K Buy
+470
New +$32.4K 0.03% 210

Other funds holding GILD

First Community Trust's GILD Position: Q2 2026 in Review

First Community Trust held its Gilead Sciences (GILD) position steady in Q2 2026 at 285 shares worth $36K. The position accounts for 0.02% of the portfolio, ranked #211.

First Community Trust first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $40K in Q4 2022. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • First Community Trust held 285 shares of Gilead Sciences worth $36K as of Q2 2026.
  • First Community Trust left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.02% of First Community Trust's portfolio in Q2 2026, its #211 holding.
  • First Community Trust first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • First Community Trust's Gilead Sciences position peaked at $40K in Q4 2022.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on First Community Trust's 13F filing for Q2 2026, filed 10 Jul 2026.